[1]. Serum presepsin level reflects macrophage activation and hemophagocytosis in bone marrow.
PloS one [巻]21 [号]4 [頁]e0344867 （2026年） [査読] 有
[DOI] [2]. Characterization of Mutation as a Targetable Driver Mutation Identified in Lung Adenocarcinoma by Comprehensive Genomic Profiling.
JCO precision oncology [巻]8 [頁]e2300538 （2024年） [査読] 有
[DOI] [機関リポジトリ][3]. Radiological and histopathological features and treatment response by subtypes of interstitial pneumonia with autoimmune features: A prospective, multicentre cohort study.
Respiratory medicine [巻]224 [頁]107577 -107577 （2024年） [査読] 有
[DOI] [4]. CD109 Attenuates Bleomycin-induced Pulmonary Fibrosis by Inhibiting TGF-β Signaling.
Journal of immunology (Baltimore, Md. : 1950) [巻]212 [号]7 [頁]1221 -1231 （2024年） [査読] 有
[DOI] [5]. Neutrophil-lymphocyte ratio being associated with mortality risk in patients receiving antifibrotic therapy
RESPIRATORY MEDICINE [巻]223 （2024年） [査読] 有
[DOI] [6]. Impact of preexisting interstitial lung disease on mortality in COVID-19 patients from the early pandemic to the delta variant epidemic: a nationwide population-based study
RESPIRATORY RESEARCH [巻]25 [号]1 （2024年） [査読] 有
[DOI] [7]. Detailed tracking of antigen and antibody levels during coronavirus disease 2019 treatment in an immunosuppressed patient with anti-neutrophil cytoplasmic autoantibody-associated vasculitis.
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy （2024年） [査読] 有
[DOI] [8]. CLEC10A expression defines functionally distinct subsets of conventional type 2 dendritic cells (cDC2) in the mouse lung.
Allergology international : official journal of the Japanese Society of Allergology （2024年） [査読] 有
[DOI] [9]. Prognostic Role of Interferon-λ3 in Anti-Melanoma Differentiation-Associated Gene 5-Positive Dermatomyositis-Associated Interstitial Lung Disease
ARTHRITIS & RHEUMATOLOGY （2024年） [査読] 有
[DOI] [機関リポジトリ][10]. Association of the lung immune prognostic index with the survival of patients with idiopathic interstitial pneumonias
RESPIROLOGY [巻]29 [号]2 [頁]136 -145 （2024年） [査読] 有
[DOI] [11]. Age dependent discrepancy between SARS-CoV-2 anti-nucleoprotein antibody and anti-RBD spike protein antibody in children reflects vaccine coverage.
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy （2024年） [査読] 有
[DOI] [12]. Pan-cancer assessment of antineoplastic therapy-induced interstitial lung disease in patients receiving subsequent therapy immediately following immune checkpoint blockade therapy
RESPIRATORY RESEARCH [巻]25 [号]1 （2024年） [査読] 有
[DOI] [13]. "Bull's-eye" Sign and Its Longitudinal Change on High-Resolution Computed Tomography in Pulmonary Sarcoidosis
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE [巻]209 [号]1 [頁]E1 -E3 （2024年） [査読] 有
[DOI] [14]. Neutrophil-lymphocyte ratio in patients with idiopathic pleuroparenchymal fibroelastosis
BMJ OPEN RESPIRATORY RESEARCH [巻]10 [号]1 （2023年） [査読] 有
[DOI] [15]. Changes in the characteristics and outcomes of COVID-19 patients from the early pandemic to the delta variant epidemic: a nationwide population-based study.
Emerging microbes & infections [巻]12 [号]1 [頁]2155250 （2023年） [査読] 有
[DOI] [16]. Utility of the MBT STAR-Cepha kit in detecting extended-spectrum β-lactamase producers in clinical urine samples and positive blood cultures using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
JOURNAL OF MICROBIOLOGICAL METHODS [巻]211 （2023年） [査読] 有
[DOI] [17]. Geriatric Nutritional Risk Index is a predictor of tolerability of antifibrotic therapy and mortality risk in patients with idiopathic pulmonary fibrosis
RESPIROLOGY [巻]28 [号]8 [頁]775 -783 （2023年） [査読] 有
[DOI] [18]. Cytokine profiling identifies circulating IL-6 and IL-15 as prognostic stratifiers in patients with non-small cell lung cancer receiving anti-PD-1/PD-L1 blockade therapy.
Cancer immunology, immunotherapy : CII [巻]72 [号]8 [頁]2717 -2728 （2023年） [査読] 有
[DOI] [19]. Standardized 3D-CT lung volumes for patients with acute exacerbation of rheumatoid arthritis-associated interstitial lung disease
RHEUMATOLOGY （2023年） [査読] 有
[DOI] [20]. Six-week oral prednisolone therapy for immune-related pneumonitis: a single-arm phase II study
JOURNAL FOR IMMUNOTHERAPY OF CANCER [巻]11 [号]7 （2023年） [査読] 有
[DOI] [21]. Cycle Threshold (Ct) Values of SARS-CoV-2 Detected with the GeneXpert
® System and a Mutation Associated with Different Target Gene Failure
CURRENT ISSUES IN MOLECULAR BIOLOGY [巻]45 [号]5 [頁]4124 -4134 （2023年） [査読] 有
[DOI] [22]. A predictive model for acute exacerbation of idiopathic interstitial pneumonias
EUROPEAN RESPIRATORY JOURNAL [巻]61 [号]5 （2023年） [査読] 有
[DOI] [機関リポジトリ][23]. Assessment of malnutrition-related risk in patients with idiopathic pleuroparenchymal fibroelastosis
ERJ OPEN RESEARCH [巻]9 [号]3 （2023年） [査読] 有
[DOI] [24]. CD109 on Dendritic Cells Regulates Airway Hyperreactivity and Eosinophilic Airway Inflammation.
American journal of respiratory cell and molecular biology [巻]68 [号]2 [頁]201 -212 （2023年） [査読] 有
[DOI] [25]. 血液培養から検出されたCandida属のCHROMagar Candidaを用いた推定とMALDI-TOF MSによる同定法の比較検討
臨床微生物学会雑誌 [巻]33 [頁]116 -120 （2023年） [査読] 有
[26]. 胸部から右肩関節へ連続する膿瘍を呈した皮膚腺病の1例
日本皮膚科学会雑誌 (公社)日本皮膚科学会 [巻]133 [号]1 [頁]55 （2023年） [査読] 有
[27]. Association between increased peripheral blood CD86-positive plasmacytoid dendritic cells and immune-related adverse events in patients with non-small cell lung cancer.
Global health & medicine [巻]4 [号]6 [頁]301 -308 （2022年） [査読] 有
[DOI] [28]. Idiopathic pleuroparenchymal fibroelastosis: three-dimensional computed tomography assessment of upper-lobe lung volume.
European respiratory journal [巻]60 [号]6 （2022年） [査読] 有
[DOI] [29]. Prognostic significance of radiological pleuroparenchymal fibroelastosis in complex lung disease: a multicentre retrospective cohort study.
Thorax （2022年） [査読] 有
[DOI] [30]. Clinical practice of high-flow nasal cannula therapy in COVID-19 pandemic era: a cross-sectional survey of respiratory physicians.
Respiratory investigation [巻]60 [号]6 [頁]779 -786 （2022年） [査読] 有
[DOI] [31]. Frequency, proportion of PF-ILD, and prognostic factors in patients with acute exacerbation of ILD related to systemic autoimmune diseases.
BMC pulmonary medicine [巻]22 [号]1 [頁]387 （2022年） [査読] 有
[DOI] [32]. Effect of Hypoxia on Pulmonary Endothelial Cells from Bleomycin-Induced Pulmonary Fibrosis Model Mice.
International journal of molecular sciences [巻]23 [号]16 （2022年） [査読] 有
[DOI] [33]. Associations of serum long-chain fatty acids with multiple organ involvement in patients with sarcoidosis.
BMC pulmonary medicine [巻]22 [号]1 [頁]290 （2022年） [査読] 有
[DOI] [34]. Serum immune modulators associated with immune-related toxicities and efficacy of atezolizumab in patients with non-small cell lung cancer.
Journal of cancer research and clinical oncology （2022年） [査読] 有
[DOI] [35]. Differential Dynamics of Humoral and Cell-Mediated Immunity with Three Doses of BNT162b2 SARS-CoV-2 Vaccine in Healthcare Workers in Japan: A Prospective Cohort Study.
Vaccines [巻]10 [号]7 （2022年） [査読] 有
[DOI] [36]. Standardised 3D-CT lung volumes for patients with idiopathic pulmonary fibrosis.
Respiratory research [巻]23 [号]1 [頁]142 （2022年） [査読] 有
[DOI] [37]. Effects of long-acting muscarinic antagonists on promoting ciliary function in airway epithelium.
BMC pulmonary medicine [巻]22 [号]1 [頁]186 （2022年） [査読] 有
[DOI] [38]. Clinical characteristics and treatment outcomes of carbapenem-resistant Enterobacterales infections in Japan.
Journal of global antimicrobial resistance （2022年） [査読] 有
[DOI] [39]. Impact of end-of-life respiratory modalities on quality of dying and death and symptom relief in patients with interstitial lung disease: a multicenter descriptive cross-sectional study.
Respiratory research [巻]23 [号]1 [頁]79 （2022年） [査読] 有
[DOI] [40]. Impact of antifibrotic therapy on lung cancer development in idiopathic pulmonary fibrosis.
Thorax （2022年） [査読] 有
[DOI] [機関リポジトリ][41]. Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: mortality and its prediction model.
Respiratory research [巻]23 [号]1 [頁]57 （2022年） [査読] 有
[DOI] [42]. Highly Sensitive and Quantitative Diagnosis of SARS-CoV-2 Using a Gold/Platinum Particle-Based Lateral Flow Assay and a Desktop Scanning Electron Microscope.
Biomedicines [巻]10 [号]2 （2022年） [査読] 有
[DOI] [43]. Association of the Geriatric Nutritional Risk Index With the Survival of Patients With Non-Small Cell Lung Cancer After Nivolumab Therapy.
Journal of immunotherapy (Hagerstown, Md. : 1997) [巻]45 [号]2 [頁]125 -131 （2022年） [査読] 有
[DOI] [44]. Involvement of autophagy in exacerbation of eosinophilic airway inflammation in a murine model of obese asthma.
Autophagy [頁]1 -13 （2022年） [査読] 有
[DOI] [45]. Chemotherapy for patients with advanced lung cancer with interstitial lung disease: a prospective observational study.
Therapeutic advances in chronic disease [巻]13 [頁]20406223221108395 （2022年） [査読] 有
[DOI] [46]. Trimethoprim-sulfamethoxazole induced eosinophilic pneumonia: A case report.
Respiratory medicine case reports [巻]37 [頁]101632 （2022年） [査読] 有
[DOI] [47]. Multiple organ infarction caused by aortic thrombus in a lung cancer patient with the mutation.
Respiratory medicine case reports [巻]36 [頁]101608 （2022年） [査読] 有
[DOI] [48]. Marked, Lasting Disease Regression and Concomitantly Induced Autoimmune Hemolytic Anemia and Hemophagocytic Lymphohistiocytosis in a Patient With Lung Adenocarcinoma and Autoantibodies Receiving Atezolizumab Plus Chemotherapy: A Case Report.
JTO clinical and research reports [巻]3 [号]1 [頁]100263 （2022年） [査読] 有
[DOI] [49]. Increased serum cholesterol and long-chain fatty acid levels are associated with the efficacy of nivolumab in patients with non-small cell lung cancer.
Cancer immunology, immunotherapy [巻]71 [号]1 [頁]203 -217 （2022年） [査読] 有
[DOI] [50]. Transient leukocytopenia following combination therapy for COVID-19.
Respiratory investigation [巻]60 [号]1 [頁]158 -161 （2022年） [査読] 有
[DOI] [51]. EGFR-Mutated Lung Adenocarcinoma Successfully Treated With Osimertinib After Spontaneous Transformation to SCLC and Adenocarcinoma With Neuroendocrine Differentiation: Case Report.
JTO clinical and research reports [巻]3 [号]1 [頁]100264 -100264 （2022年） [査読] 有
[DOI] [52]. Association of the Geriatric Nutritional Risk Index with the survival of patients with non-small-cell lung cancer after platinum-based chemotherapy.
BMC pulmonary medicine [巻]21 [号]1 [頁]409 （2021年） [査読] 有
[DOI] [53]. Clinical Significance of Cold-Inducible RNA-Binding Protein in Idiopathic Pulmonary Fibrosis.
Chest [巻]160 [号]6 [頁]2149 -2157 （2021年） [査読] 有
[DOI] [機関リポジトリ][54]. Radiological pleuroparenchymal fibroelastosis-like lesion in idiopathic interstitial pneumonias.
Respiratory research [巻]22 [号]1 [頁]290 （2021年） [査読] 有
[DOI] [55]. Serum S100A8 and S100A9 as prognostic biomarkers in acute exacerbation of idiopathic pulmonary fibrosis.
Respiratory investigation [巻]59 [号]6 [頁]827 -836 （2021年） [査読] 有
[DOI] [機関リポジトリ][56]. MET Amplification and Efficacy of Nivolumab in Patients With NSCLC.
JTO clinical and research reports [巻]2 [号]11 [頁]100239 -100239 （2021年） [査読] 有
[DOI] [57]. Efficacy of immune checkpoint inhibitors in non-small cell lung cancer with uncommon histology: a propensity-score-matched analysis.
BMC pulmonary medicine [巻]21 [号]1 [頁]309 （2021年） [査読] 有
[DOI] [58]. Combined assessment of the GAP index and body mass index at antifibrotic therapy initiation for prognosis of idiopathic pulmonary fibrosis.
Scientific reports [巻]11 [号]1 [頁]18579 （2021年） [査読] 有
[DOI] [59]. Diagnostic and prognostic significance of serum angiopoietin-1 and -2 concentrations in patients with pulmonary hypertension.
Scientific reports [巻]11 [号]1 [頁]15502 （2021年） [査読] 有
[DOI] [60]. Comparative assessment of NOIR-SS and ddPCR for ctDNA detection of EGFR L858R mutations in advanced L858R-positive lung adenocarcinomas.
Scientific reports [巻]11 [号]1 [頁]14999 （2021年） [査読] 有
[DOI] [61]. Switching antifibrotics in patients with idiopathic pulmonary fibrosis: a multi-center retrospective cohort study.
BMC pulmonary medicine [巻]21 [号]1 [頁]221 （2021年） [査読] 有
[DOI] [62]. Conventional type 2 lung dendritic cells are potent inducers of follicular helper T cells in the asthmatic lung.
Allergology international [巻]70 [号]3 [頁]351 -359 （2021年） [査読] 有
[DOI] [63]. Prognostic classification in acute exacerbation of idiopathic pulmonary fibrosis: a multicentre retrospective cohort study.
Scientific reports [巻]11 [号]1 [頁]9120 （2021年） [査読] 有
[DOI] [64]. Prognostic significance of peripheral blood monocyte and neutrophil counts in rheumatoid arthritis-associated interstitial lung disease.
Respiratory medicine [巻]182 [頁]106420 （2021年） [査読] 有
[DOI] [65]. Simple method for detecting idiopathic interstitial pneumonias by measuring vertical lung length on chest X-ray.
Scientific reports [巻]11 [号]1 [頁]7669 （2021年） [査読] 有
[DOI] [66]. Prognostic and Clinical Value of Cluster Analysis in Idiopathic Pleuroparenchymal Fibroelastosis Phenotypes.
Journal of clinical medicine [巻]10 [号]7 （2021年） [査読] 有
[DOI] [67]. Evaluation of MBT STAR-Cepha and MBT STAR-Carba kits for the detection of extended-spectrum β-lactamases and carbapenemase producing microorganisms using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Journal of microbiological methods [巻]183 [頁]106166 （2021年） [査読] 有
[DOI] [機関リポジトリ][68]. Prednisolone and tacrolimus versus prednisolone and cyclosporin A to treat polymyositis/dermatomyositis-associated ILD: A randomized, open-label trial.
Respirology [巻]26 [号]4 [頁]370 -377 （2021年） [査読] 有
[DOI] [69]. Quality of dying and death in patients with interstitial lung disease compared with lung cancer: an observational study.
Thorax [巻]76 [号]3 [頁]248 -255 （2021年） [査読] 有
[DOI] [70]. Cluster analysis-based clinical phenotypes of idiopathic interstitial pneumonias: associations with acute exacerbation and overall survival.
BMC pulmonary medicine [巻]21 [号]1 [頁]63 （2021年） [査読] 有
[DOI] [71]. Clinical Significance of Interstitial Lung Disease and Its Acute Exacerbation in Microscopic Polyangiitis.
Chest [巻]159 [号]6 [頁]2334 -2345 （2021年） [査読] 有
[DOI] [機関リポジトリ][72]. Subcutaneous injection of interferon gamma therapy could be useful for anti-IFN-γ autoantibody associated disseminated nontuberculous mycobacterial infection.
Journal of infection and chemotherapy [巻]27 [号]2 [頁]373 -378 （2021年） [査読] 有
[DOI] [73]. Cause of mortality and sarcopenia in patients with idiopathic pulmonary fibrosis receiving antifibrotic therapy.
Respirology [巻]26 [号]2 [頁]171 -179 （2021年） [査読] 有
[DOI] [機関リポジトリ][74]. Erlotinib and bevacizumab in elderly patients ≥75 years old with non-small cell lung cancer harboring epidermal growth factor receptor mutations.
Investigational new drugs [巻]39 [号]1 [頁]210 -216 （2021年） [査読] 有
[DOI] [75]. Predictors for bronchoalveolar lavage recovery failure in diffuse parenchymal lung disease.
Scientific reports [巻]11 [号]1 [頁]1682 （2021年） [査読] 有
[DOI] [76]. Pneumothorax in Patients with Idiopathic Pleuroparenchymal Fibroelastosis: Incidence, Clinical Features, and Risk Factors.
Respiration [巻]100 [号]1 [頁]19 -26 （2021年） [査読] 有
[DOI] [77]. Prophylactic granulocyte-colony stimulating factor in patients with lung neuroendocrine carcinoma receiving platinum agents plus etoposide.
Cancer treatment and research communications [巻]29 [頁]100493 （2021年） [査読] 有
[DOI] [78]. Daptomycin resistant Enterococcus faecalis has a mutation in liaX, which encodes a surface protein that inhibits the LiaFSR systems and cell membrane remodeling.
Journal of infection and chemotherapy [巻]27 [号]1 [頁]90 -93 （2021年） [査読] 有
[DOI] [機関リポジトリ][79]. Palliative Care for Idiopathic Pulmonary Fibrosis Patients: Pulmonary Physicians' View.
Journal of pain and symptom management [巻]60 [号]5 [頁]933 -940 （2020年） [査読] 有
[DOI] [80]. Influenza A virus enhances ciliary activity and mucociliary clearance via TLR3 in airway epithelium.
Respiratory research [巻]21 [号]1 [頁]282 （2020年） [査読] 有
[DOI] [81]. Development of a novel T cell-oriented vaccine using CTL/Th-hybrid epitope long peptide and biodegradable microparticles, against an intracellular bacterium.
Microbiology and immunology [巻]64 [号]10 [頁]666 -678 （2020年） [査読] 有
[DOI] [82]. Disease course and prognosis of pleuroparenchymal fibroelastosis compared with idiopathic pulmonary fibrosis.
Respiratory medicine [巻]171 [頁]106078 （2020年） [査読] 有
[DOI] [機関リポジトリ][83]. Evaluation of Programmed Death Ligand 1 (PD-L1) Gene Amplification and Response to Nivolumab Monotherapy in Non-small Cell Lung Cancer.
JAMA network open [巻]3 [号]9 [頁]e2011818 （2020年） [査読] 有
[DOI] [84]. Assessment of Immune-Related Interstitial Lung Disease in Patients With NSCLC Treated with Immune Checkpoint Inhibitors: A Multicenter Prospective Study.
Journal of thoracic oncology [巻]15 [号]8 [頁]1317 -1327 （2020年） [査読] 有
[DOI] [85]. Clinical significance of serum S100 calcium-binding protein A4 in idiopathic pulmonary fibrosis.
Respirology [巻]25 [号]7 [頁]743 -749 （2020年） [査読] 有
[DOI] [86]. Intravoxel incoherent motion magnetic resonance imaging for predicting the long-term efficacy of immune checkpoint inhibitors in patients with non-small-cell lung cancer.
Lung cancer [巻]143 [頁]47 -54 （2020年） [査読] 有
[DOI] [87]. Author Correction: Macrophage Mannose Receptor CD206 Predicts Prognosis in Community-acquired Pneumonia.
Scientific reports [巻]10 [号]1 [頁]3324 （2020年） [査読] 有
[DOI] [88]. Pneumothorax in connective tissue disease-associated interstitial lung disease.
PloS one [巻]15 [号]7 [頁]e0235624 （2020年） [査読] 有
[DOI] [89]. Pulse oximetric saturation to fraction of inspired oxygen (SpO2/FIO2) ratio 24 hours after high-flow nasal cannula (HFNC) initiation is a good predictor of HFNC therapy in patients with acute exacerbation of interstitial lung disease.
Therapeutic advances in respiratory disease [巻]14 [頁]1753466620906327 -1753466620906327 （2020年） [査読] 有
[DOI] [90]. Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis.
Therapeutic advances in respiratory disease [巻]14 [頁]1753466620935774 -1753466620935774 （2020年） [査読] 有
[DOI] [91]. Prognostic significance of forced vital capacity decline prior to and following antifibrotic therapy in idiopathic pulmonary fibrosis.
Therapeutic advances in respiratory disease [巻]14 [頁]1753466620953783 -1753466620953783 （2020年） [査読] 有
[DOI] [92]. Macrophage Mannose Receptor CD206 Predicts Prognosis in Community-acquired Pneumonia.
Scientific reports [巻]9 [号]1 [頁]18750 （2019年） [査読] 有
[DOI] [93]. 市中肺炎に対するレボフロキサシン・スイッチ療法の有効性・安全性の検討
新薬と臨牀 (株)医薬情報研究所 [巻]68 [号]12 [頁]1519 -1531 （2019年） [査読] 有
[94]. Successful classification of macrophage-mannose receptor CD206 in severity of anti-MDA5 antibody positive dermatomyositis associated ILD.
Rheumatology [巻]58 [号]12 [頁]2143 -2152 （2019年） [査読] 有
[DOI] [95]. Synchronous Occurrence of Bazex Syndrome and Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome in a Patient with Lung Cancer.
Internal medicine [巻]58 [号]22 [頁]3267 -3271 （2019年） [査読] 有
[DOI] [96]. Simultaneous Occurrence of Sarcoidosis and Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis in a Patient with Lung Cancer.
Internal medicine [巻]58 [号]22 [頁]3299 -3304 （2019年） [査読] 有
[DOI] [97]. Prognostic impact of an early marginal decline in forced vital capacity in idiopathic pulmonary fibrosis patients treated with pirfenidone.
Respiratory investigation [巻]57 [号]6 [頁]552 -560 （2019年） [査読] 有
[DOI] [98]. Prognostic factors for primary Sjögren's syndrome-associated interstitial lung diseases.
Respiratory medicine [巻]159 [頁]105811 （2019年） [査読] 有
[DOI] [99]. Body composition changes successfully classify prognosis in patients with mycobacterium avium complex lung disease.
The Journal of infection [巻]79 [号]4 [頁]341 -348 （2019年） [査読] 有
[DOI] [100]. Clinical Significance of Serum Chitotriosidase Level in Anti-MDA5 Antibody-positive Dermatomyositis-associated Interstitial Lung Disease.
The Journal of rheumatology [巻]46 [号]8 [頁]935 -942 （2019年） [査読] 有
[DOI] [101]. Efficacy of corticosteroid and intravenous cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis: A propensity score-matched analysis.
Respirology [巻]24 [号]8 [頁]792 -798 （2019年） [査読] 有
[DOI] [102]. Analysis of serum adiponectin and leptin in patients with acute exacerbation of idiopathic pulmonary fibrosis.
Scientific reports [巻]9 [号]1 [頁]10484 （2019年） [査読] 有
[DOI] [103]. Olanzapine-containing antiemetic therapy for the prevention of carboplatin-induced nausea and vomiting.
Cancer chemotherapy and pharmacology [巻]84 [号]1 [頁]147 -153 （2019年） [査読] 有
[DOI] [104]. Frequency and clinical relevance of anti-cyclic citrullinated peptide antibody in idiopathic interstitial pneumonias.
Respiratory medicine [巻]154 [頁]102 -108 （2019年） [査読] 有
[DOI] [105]. Switch maintenance therapy with S-1 after induction therapy with carboplatin and nanoparticle albumin-bound paclitaxel in advanced lung squamous cell carcinoma.
Investigational new drugs [巻]37 [号]3 [頁]531 -537 （2019年） [査読] 有
[DOI] [106]. 全自動尿中有形成分分析装置UF-5000によるEscherichia coliを対象とした迅速な薬剤感受性検査法の構築
臨床病理 日本臨床検査医学会 ; 1953- [巻]67 [号]6 [頁]569 -576 （2019年） [査読] 有
[URL] [107]. Physiological and morphological differences of airways between COPD and asthma-COPD overlap.
Scientific reports [巻]9 [号]1 [頁]7818 （2019年） [査読] 有
[DOI] [108]. Efficacy of Glucocorticoids and Calcineurin Inhibitors for Anti-aminoacyl-tRNA Synthetase Antibody-positive Polymyositis/dermatomyositis-associated Interstitial Lung Disease: A Propensity Score-matched Analysis.
The Journal of rheumatology [巻]46 [号]5 [頁]509 -517 （2019年） [査読] 有
[DOI] [109]. Methotrexate-associated Lymphoproliferative Disorder with Diffuse Ground-Glass Opacities.
American journal of respiratory and critical care medicine [巻]199 [号]8 [頁]1031 -1033 （2019年） [査読] 有
[DOI] [110]. Identification of risk factors and development of detection algorithm for denosumab-induced hypocalcaemia.
Journal of clinical pharmacy and therapeutics [巻]44 [号]1 [頁]62 -68 （2019年） [査読] 有
[DOI] [111]. A rapid and simple detection method for phenotypic antimicrobial resistance in Escherichia coli by loop-mediated isothermal amplification.
Journal of medical microbiology [巻]68 [号]2 [頁]169 -177 （2019年） [査読] 有
[DOI] [112]. Clinical features of three-dimensional computed tomography-based radiologic phenotypes of chronic obstructive pulmonary disease.
International journal of chronic obstructive pulmonary disease [巻]14 [頁]1333 -1342 （2019年） [査読] 有
[DOI] [113]. Once-daily fluticasone furoate/vilanterol combination versus twice-daily budesonide/formoterol combination in the treatment of controlled stable asthma: a randomized crossover trial.
Journal of asthma and allergy [巻]12 [頁]253 -261 （2019年） [査読] 有
[DOI] [114]. Effect of PD-1 inhibitor on exhaled nitric oxide and pulmonary function in non-small cell lung cancer patients with and without COPD.
International journal of chronic obstructive pulmonary disease [巻]14 [頁]1867 -1877 （2019年） [査読] 有
[DOI] [115]. Correlation of the modified Medical Research Council dyspnea scale with airway structure assessed by three-dimensional CT in patients with chronic obstructive pulmonary disease.
Respiratory medicine [巻]146 [頁]76 -80 （2019年） [査読] 有
[DOI] [116]. Differences in clinical features of acute exacerbation between connective tissue disease-associated interstitial pneumonia and idiopathic pulmonary fibrosis.
Chronic respiratory disease [巻]16 [頁]1479972318809476 -1479972318809476 （2019年） [査読] 有
[DOI] [117]. An Acquired Epidermal Growth Factor Receptor T790M Mutation after the Addition of Bevacizumab to Preceding Erlotinib Monotherapy in a Lung Cancer Patient with Leptomeningeal Metastases.
Internal medicine (Tokyo, Japan) [巻]57 [号]23 [頁]3423 -3427 （2018年） [査読] 有
[DOI]